Stockscreener 앱 받기
25.27
2.43%
-0.63
시간 외 거래:
25.27
Amphastar Pharmaceuticals Inc 주식(AMPH)의 최신 뉴스
Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded to "Hold" at Barclays - MarketBeat
Is Amphastar Pharmaceuticals Mispriced After a Tough Year and Promising Cash Flow Outlook in 2025? - Sahm
Barclays Initiates Coverage of Amphastar Pharmaceuticals (AMPH) with Equal-Weight Recommendation - Nasdaq
Amphastar Pharmaceuticals (NASDAQ:AMPH) Coverage Initiated by Analysts at Barclays - MarketBeat
Barclays Initiates Amphastar Pharmaceuticals at Equalweight With $30 Price Target - marketscreener.com
Marshall Wace LLP Sells 183,037 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Falls 5.2% in Past Week as One-year Earnings and Shareholder Returns Continue Downward Trend - 富途牛牛
American Century Companies Inc. Sells 74,832 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Is Amphastar Pharmaceuticals Stock Built to Withstand a Pullback? - Trefis
Amphastar Pharmaceuticals, Inc. $AMPH Shares Bought by Quantbot Technologies LP - MarketBeat
Why (AMPH) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Would You Still Hold Amphastar Pharmaceuticals Stock If It Fell 30%? - Trefis
Capital Fund Management S.A. Takes $931,000 Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead? - Yahoo Finance
How Amphastar Pharmaceuticals Inc. (29A) stock expands through international marketsOptions Play & Free Community Supported Trade Ideas - Newser
Will Amphastar Pharmaceuticals Inc. stock outperform Nasdaq indexJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - Newser
Will Amphastar Pharmaceuticals Inc. (29A) stock recover faster than industry2025 Retail Activity & Daily Profit Focused Stock Screening - Newser
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Rating of "Hold" from Analysts - MarketBeat
Amphastar Pharmaceuticals (AMPH) Stock Trades Up, Here Is Why - The Globe and Mail
Will Amphastar Pharmaceuticals Inc. (29A) stock benefit from infrastructure bill2025 Price Targets & Capital Protection Trade Alerts - Newser
Trend Recap: How strong is Amphastar Pharmaceuticals Inc stock revenue growth - BỘ NỘI VỤ
Will Amphastar Pharmaceuticals Inc. (29A) stock deliver stable dividendsWeekly Trade Recap & Precise Buy Zone Identification - Newser
Is Amphastar Pharmaceuticals Inc. stock a good choice for value investorsTrade Analysis Report & Long-Term Safe Return Strategies - Newser
Is Amphastar Pharmaceuticals Inc. (29A) stock at risk of policy regulationQuarterly Performance Summary & High Yield Equity Trading Tips - Newser
Can Amphastar Pharmaceuticals Inc. (29A) stock double in coming years2025 Price Targets & Real-Time Price Movement Reports - Newser
Creative Planning Acquires 22,493 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Geode Capital Management LLC Buys 18,161 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals (AMPH) Jumps 6.5% After Q3 Beat and Conference Reveal—Has the Investment Case Shifted? - Yahoo Finance
Amphastar Pharmaceuticals (AMPH) Is Up 6.5% After Earnings Beat and Pipeline Expansion—What's Changed? - Sahm
A Look at Amphastar Pharmaceuticals (AMPH) Valuation Following Strong Quarterly Results and Pipeline Progress - Yahoo Finance
VP Zhou Files To Sell 20,000 Of Amphastar Pharmaceuticals Inc [AMPH] - TradingView
SG Americas Securities LLC Acquires Shares of 24,448 Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
A Look at Amphastar Pharmaceuticals’s Valuation After Upbeat Earnings and Strategic Pipeline Moves (AMPH) - Sahm
Will Amphastar’s (AMPH) Q3 Earnings Beat Amid Margin Pressure Shift Its Competitive Narrative? - Sahm
Does Amphastar’s New Product Approvals Signal a Turning Point for the Stock in 2025? - Sahm
Magnetar Financial LLC Invests $306,000 in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar (AMPH) Q3 2025 Earnings Call Transcript - The Globe and Mail
Richard Prins Sells 4,179 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock - MarketBeat
Understanding Momentum Shifts in (AMPH) - news.stocktradersdaily.com
Amphastar pharma director Prins sells $113,253 in shares By Investing.com - Investing.com Canada
[Form 4] Amphastar Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Amphastar Pharmaceuticals Director Sells Shares - TradingView
Dir Prins Sells 4,179 ($113.3K) Of Amphastar Pharmaceuticals Inc [AMPH] - TradingView
Amphastar Pharmaceuticals- Growth has been impressive, Can it continue? - Yahoo Finance
Amphastar Pharmaceuticals- Growth has been impressive, Can it c - GuruFocus
Dynamic Technology Lab Private Ltd Takes Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference - standard-journal.com
Amphastar Pharmaceuticals, Inc. (AMPH) Stock forecasts - Yahoo Finance UK
Amphastar Shares Surge Following Impressive Quarterly Earnings Report - Ad-hoc-news.de
Amphastar stock hits 52-week low at $31.54 amid market challenges - MSN
The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - The Globe and Mail
How Amphastar Pharmaceuticals Inc. stock reacts to oil pricesWeekly Investment Summary & Real-Time Market Sentiment Reports - newser.com
Why Amphastar Pharmaceuticals Inc. (29A) stock is listed among top recommendationsQuarterly Trade Report & Safe Entry Momentum Tips - newser.com
Amphastar Expects Mysterious Inhaler Candidate To Be The ‘Most Meaningful’ Revenue Driver In 2026 - Citeline News & Insights
1.48%
0.09%
자본화:
|
볼륨(24시간):